149 related articles for article (PubMed ID: 33523584)
1. A combination of extracellular matrix- and interferon-associated signatures identifies high-grade breast cancers with poor prognosis.
Lecchi M; Verderio P; Cappelletti V; De Santis F; Paolini B; Monica M; Sangaletti S; Pupa SM; Iorio MV; Bianchi G; Gennaro M; Fucà G; De Braud F; Tagliabue E; Di Nicola M
Mol Oncol; 2021 May; 15(5):1345-1357. PubMed ID: 33523584
[TBL] [Abstract][Full Text] [Related]
2. Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.
Triulzi T; Casalini P; Sandri M; Ratti M; Carcangiu ML; Colombo MP; Balsari A; Ménard S; Orlandi R; Tagliabue E
PLoS One; 2013; 8(2):e56761. PubMed ID: 23441215
[TBL] [Abstract][Full Text] [Related]
3. Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer.
Callari M; Musella V; Di Buduo E; Sensi M; Miodini P; Dugo M; Orlandi R; Agresti R; Paolini B; Carcangiu ML; Cappelletti V; Daidone MG
Mol Oncol; 2014 Oct; 8(7):1278-89. PubMed ID: 24853384
[TBL] [Abstract][Full Text] [Related]
4. Infrared Spectroscopic Imaging Visualizes a Prognostic Extracellular Matrix-Related Signature in Breast Cancer.
Tiwari S; Triulzi T; Holton S; Regondi V; Paolini B; Tagliabue E; Bhargava R
Sci Rep; 2020 Mar; 10(1):5442. PubMed ID: 32214177
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment.
Rybinska I; Sandri M; Bianchi F; Orlandi R; De Cecco L; Gasparini P; Campiglio M; Paolini B; Sfondrini L; Tagliabue E; Triulzi T
Cells; 2020 Feb; 9(2):. PubMed ID: 32069815
[TBL] [Abstract][Full Text] [Related]
6. The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancer.
Winslow S; Lindquist KE; Edsjö A; Larsson C
BMC Cancer; 2016 Nov; 16(1):841. PubMed ID: 27809802
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity.
Sangaletti S; Tripodo C; Santangelo A; Castioni N; Portararo P; Gulino A; Botti L; Parenza M; Cappetti B; Orlandi R; Tagliabue E; Chiodoni C; Colombo MP
Cell Rep; 2016 Sep; 17(1):233-248. PubMed ID: 27681434
[TBL] [Abstract][Full Text] [Related]
8. Programmed death-ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21-gene and 70-gene signatures in estrogen receptor-positive disease.
Zerdes I; Sifakis EG; Matikas A; Chrétien S; Tobin NP; Hartman J; Rassidakis GZ; Bergh J; Foukakis T
Mol Oncol; 2020 May; 14(5):951-963. PubMed ID: 32115850
[TBL] [Abstract][Full Text] [Related]
9. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.
Amara D; Wolf DM; van 't Veer L; Esserman L; Campbell M; Yau C
Breast Cancer Res Treat; 2017 Jan; 161(1):41-50. PubMed ID: 27815749
[TBL] [Abstract][Full Text] [Related]
10. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.
Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
[TBL] [Abstract][Full Text] [Related]
11. Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.
Karn T; Pusztai L; Holtrich U; Iwamoto T; Shiang CY; Schmidt M; Müller V; Solbach C; Gaetje R; Hanker L; Ahr A; Liedtke C; Ruckhäberle E; Kaufmann M; Rody A
PLoS One; 2011; 6(12):e28403. PubMed ID: 22220191
[TBL] [Abstract][Full Text] [Related]
12. An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic risk.
Yau C; Sninsky J; Kwok S; Wang A; Degnim A; Ingle JN; Gillett C; Tutt A; Waldman F; Moore D; Esserman L; Benz CC
Breast Cancer Res; 2013; 15(5):R103. PubMed ID: 24172169
[TBL] [Abstract][Full Text] [Related]
13. ETV7 regulates breast cancer stem-like cell features by repressing IFN-response genes.
Pezzè L; Meškytė EM; Forcato M; Pontalti S; Badowska KA; Rizzotto D; Skvortsova II; Bicciato S; Ciribilli Y
Cell Death Dis; 2021 Jul; 12(8):742. PubMed ID: 34315857
[TBL] [Abstract][Full Text] [Related]
14. A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis.
Wang DY; Done SJ; McCready DR; Boerner S; Kulkarni S; Leong WL
Breast Cancer Res; 2011 Sep; 13(5):R92. PubMed ID: 21939527
[TBL] [Abstract][Full Text] [Related]
15. Emerging immune gene signatures as prognostic or predictive biomarkers in breast cancer.
Kwon MJ
Arch Pharm Res; 2019 Nov; 42(11):947-961. PubMed ID: 31707598
[TBL] [Abstract][Full Text] [Related]
16. Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival.
Joseph C; Alsaleem M; Orah N; Narasimha PL; Miligy IM; Kurozumi S; Ellis IO; Mongan NP; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jul; 182(2):267-282. PubMed ID: 32445177
[TBL] [Abstract][Full Text] [Related]
17. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
18. A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer.
Wang J; Yang Z; Zhang C; Ouyang J; Zhang G; Wu C
Gene; 2020 Nov; 761():145049. PubMed ID: 32791092
[TBL] [Abstract][Full Text] [Related]
19. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
[TBL] [Abstract][Full Text] [Related]
20. Grading breast cancer tissues using molecular portraits.
Olsson N; Carlsson P; James P; Hansson K; Waldemarson S; Malmström P; Fernö M; Ryden L; Wingren C; Borrebaeck CA
Mol Cell Proteomics; 2013 Dec; 12(12):3612-23. PubMed ID: 23982162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
